- £899.62m
- £1.18bn
- £647.30m
- 74
- 19
- 70
- 55
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 13.59 | ||
| PEG Ratio (f) | 1.85 | ||
| EPS Growth (f) | 7.93% | ||
| Dividend Yield (f) | 0.74% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.44 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 37.48 | ||
| Price to Sales | 1.36 | ||
| EV to EBITDA | 10.52 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 8.37% | ||
| Return on Equity | 8.64% | ||
| Operating Margin | 7.37% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 427.8 | 510.1 | 554.2 | 588.9 | 647.3 | 686.25 | 721.67 | 9.75% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +4.66 | +118.99 | +75.76 | +49.56 | -29.57 | +69.53 | +7.73 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CVS Group plc (CVS) is a United Kingdom-based company, which is engaged in providing veterinary services with operations in the United Kingdom and Australia. The Company is focused on providing high-quality clinical services to its clients and their animals. The Company’s segments include Veterinary Practices, Laboratories, and Online Retail Business. The Company has approximately 460 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. The Laboratories division provides diagnostic services and in-practice laboratory analyzers to CVS practices and third-party-owned veterinary surgeries. The Online Retail Business includes Animed Direct, which sells prescription and non-prescription medicines. The Company’s MiPet and EqueVet-Pro are quality and technically advanced veterinary products that can help manage certain conditions, treat acute or chronic illnesses, and help keep a pet in good condition.
Directors
- Richard Connell CHM (66)
- Richard Fairman CEO (54)
- Robin Alfonso CFO (42)
- Ben Jacklin COO (37)
- Jenny Farrer SEC (44)
- David Wilton NED
- Richard Gray NID (64)
- Deborah Kemp NID (60)
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 13th, 2007
- Public Since
- October 10th, 2007
- No. of Employees
- 8,822
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
London Stock Exchange- Shares in Issue
- 71,740,184
- Address
- C V S House, Owen Road, DISS, IP22 4ER
- Web
- https://www.cvsukltd.co.uk/
- Phone
- +44 1379644288
- Auditors
- Deloitte LLP
Latest News for CVSG
Upcoming Events for CVSG
Full Year 2025 CVS Group PLC Trading Statement Release
Full Year 2025 CVS Group PLC Earnings Release
CVS Group PLC Annual Shareholders Meeting
Similar to CVSG
Chill Brands
London Stock Exchange
Hellenic Dynamics
London Stock Exchange
Imaging Biometrics
London Stock Exchange
Integrated Diagnostics Holdings
London Stock Exchange
One Health
London Stock Exchange
FAQ
As of Today at 20:07 UTC, shares in CVS are trading at 1,254.00p. This share price information is delayed by 15 minutes.
Shares in CVS last closed at 1,254.00p and the price had moved by +24.16% over the past 365 days. In terms of relative price strength the CVS share price has outperformed the FTSE All Share Index by +15.32% over the past year.
The overall consensus recommendation for CVS is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe CVS dividend yield is 0.64% based on the trailing twelve month period.
Last year, CVS paid a total dividend of £0.08, and it currently has a trailing dividend yield of 0.64%. We do not have any data on when CVS is to next pay dividends.
We do not have data on when CVS is to next pay dividends. The historic dividend yield on CVS shares is currently 0.64%.
To buy shares in CVS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 1,254.00p, shares in CVS had a market capitalisation of £899.62m.
Here are the trading details for CVS:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: CVSG
Based on an overall assessment of its quality, value and momentum CVS is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in CVS is 1,533.33p. That is 22.28% above the last closing price of 1,254.00p.
Analysts covering CVS currently have a consensus Earnings Per Share (EPS) forecast of £0.86 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CVS. Over the past six months, its share price has outperformed the FTSE All Share Index by +39.69%.
As of the last closing price of 1,254.00p, shares in CVS were trading +22.4% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The CVS PE ratio based on its reported earnings over the past 12 months is 13.59. The shares last closed at 1,254.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
CVS' management team is headed by:
- Richard Connell - CHM
- Richard Fairman - CEO
- Robin Alfonso - CFO
- Ben Jacklin - COO
- Jenny Farrer - SEC
- David Wilton - NED
- Richard Gray - NID
- Deborah Kemp - NID